Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial

DOI Full Paper Access

12

Citations

42

References

2025

Year

María Gión, Isabel Blancas, Patricia Cortez-Castedo, Alfonso Cortés, Frederik Marmé, Salvador Blanch, Serafín Morales, Nieves Díaz, Isabel Calvo-Plaza, Sabela Recalde,

Nature Medicine

References

	Year	Citations

Page 1